L'Occitane International S.A. (0973.HK)
HKD 33.8
(0.3%)
HKD 33.8
(0.3%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 393.97 Million EUR | 91.45% |
| 2022 | 432.87 Million EUR | -53.37% |
| 2021 | 468.08 Million EUR | 3.39% |
| 2020 | 398.24 Million EUR | 8.24% |
| 2019 | 384.27 Million EUR | 77.19% |
| 2018 | 217.95 Million EUR | 7.83% |
| 2017 | 203.28 Million EUR | -14.91% |
| 2016 | 238.38 Million EUR | 5.8% |
| 2015 | 225.44 Million EUR | -4.18% |
| 2014 | 233.49 Million EUR | 34.14% |
| 2013 | 174.1 Million EUR | -13.2% |
| 2012 | 201.53 Million EUR | 2.4% |
| 2011 | 197.2 Million EUR | 22.06% |
| 2010 | 161.55 Million EUR | 20.53% |
| 2009 | 134.03 Million EUR | 30.11% |
| 2008 | 103.01 Million EUR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 Q4 | 117.77 Million EUR | 0.0% |
| 2023 Q1 | 56.44 Million EUR | -57.53% |
| 2023 Q2 | 56.44 Million EUR | 0.0% |
| 2023 FY | - EUR | 91.45% |
| 2023 Q3 | 117.77 Million EUR | 108.64% |
| 2022 Q3 | 132.89 Million EUR | 99.98% |
| 2022 Q2 | 66.45 Million EUR | 0.0% |
| 2022 FY | - EUR | -53.37% |
| 2022 Q1 | 66.45 Million EUR | -48.01% |
| 2022 Q4 | 132.89 Million EUR | 0.0% |
| 2021 Q3 | 127.82 Million EUR | 135.67% |
| 2021 Q1 | 54.23 Million EUR | -53.91% |
| 2021 Q2 | 54.23 Million EUR | 0.0% |
| 2021 Q4 | 127.82 Million EUR | 0.0% |
| 2021 FY | - EUR | 3.39% |
| 2020 FY | - EUR | 8.24% |
| 2020 Q1 | 32.9 Million EUR | -63.55% |
| 2020 Q2 | 32.9 Million EUR | 0.0% |
| 2020 Q3 | 117.67 Million EUR | 257.62% |
| 2020 Q4 | 117.67 Million EUR | 0.0% |
| 2019 Q3 | 90.27 Million EUR | 139.92% |
| 2019 FY | - EUR | 77.19% |
| 2019 Q4 | 90.27 Million EUR | 0.0% |
| 2019 Q2 | 37.62 Million EUR | 0.0% |
| 2019 Q1 | 37.62 Million EUR | -57.91% |
| 2018 FY | - EUR | 7.83% |
| 2018 Q4 | 89.39 Million EUR | 0.0% |
| 2018 Q3 | 89.39 Million EUR | 374.75% |
| 2018 Q1 | 18.83 Million EUR | -75.47% |
| 2018 Q2 | 18.83 Million EUR | 0.0% |
| 2017 Q2 | 22.4 Million EUR | 0.0% |
| 2017 FY | - EUR | -14.91% |
| 2017 Q3 | 76.77 Million EUR | 242.73% |
| 2017 Q4 | 76.77 Million EUR | 0.0% |
| 2017 Q1 | 22.4 Million EUR | -74.22% |
| 2016 Q4 | 86.88 Million EUR | 0.0% |
| 2016 Q3 | 86.88 Million EUR | 235.24% |
| 2016 Q2 | 25.91 Million EUR | 0.0% |
| 2016 Q1 | 25.91 Million EUR | -67.92% |
| 2016 FY | - EUR | 5.8% |
| 2015 Q4 | 80.78 Million EUR | 0.0% |
| 2015 FY | - EUR | -4.18% |
| 2015 Q1 | 30.84 Million EUR | -61.48% |
| 2015 Q2 | 30.84 Million EUR | 0.0% |
| 2015 Q3 | 80.78 Million EUR | 161.94% |
| 2014 Q2 | 30.11 Million EUR | 0.0% |
| 2014 FY | - EUR | 34.14% |
| 2014 Q4 | 80.05 Million EUR | 0.0% |
| 2014 Q1 | 30.11 Million EUR | -55.21% |
| 2014 Q3 | 80.05 Million EUR | 165.88% |
| 2013 FY | - EUR | -13.2% |
| 2013 Q1 | 22.51 Million EUR | -66.82% |
| 2013 Q2 | 22.51 Million EUR | 0.0% |
| 2013 Q3 | 67.23 Million EUR | 198.64% |
| 2013 Q4 | 67.23 Million EUR | 0.0% |
| 2012 Q4 | 67.84 Million EUR | 0.0% |
| 2012 Q1 | 30.96 Million EUR | -36.2% |
| 2012 Q2 | 30.96 Million EUR | 0.0% |
| 2012 Q3 | 67.84 Million EUR | 119.06% |
| 2012 FY | - EUR | 2.4% |
| 2011 Q4 | 48.54 Million EUR | 0.0% |
| 2011 FY | - EUR | 22.06% |
| 2011 Q1 | 39.58 Million EUR | 0.0% |
| 2011 Q2 | 39.58 Million EUR | 0.0% |
| 2011 Q3 | 48.54 Million EUR | 22.62% |
| 2010 FY | - EUR | 20.53% |
| 2010 Q4 | 39.58 Million EUR | 0.0% |
| 2010 Q3 | 39.58 Million EUR | 16.5% |
| 2010 Q2 | 33.98 Million EUR | 0.0% |
| 2010 Q1 | 33.98 Million EUR | 0.0% |
| 2009 Q4 | 33.98 Million EUR | 0.0% |
| 2009 Q2 | 24.67 Million EUR | 0.0% |
| 2009 Q1 | 24.67 Million EUR | 0.0% |
| 2009 FY | - EUR | 30.11% |
| 2009 Q3 | 33.98 Million EUR | 37.75% |
| 2008 FY | - EUR | 0.0% |
| 2008 Q3 | 24.67 Million EUR | 0.0% |
| 2008 Q4 | 24.67 Million EUR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Natural Beauty Bio-Technology Limited | 22.91 Million HKD | -1619.518% |
| Innovative Pharmaceutical Biotech Limited | 317.74 Million HKD | -23.991% |
| China Overseas Nuoxin International Holdings Limited | 2.02 Million HKD | -19317.25% |
| Prosperous Future Holdings Limited | -19.68 Million HKD | 2101.3% |
| Huasheng International Holding Limited | 19.67 Million HKD | -1902.114% |
| Fourace Industries Group Holdings Limited | 61.52 Million HKD | -540.351% |
| Evergreen Products Group Limited | 140.78 Million HKD | -179.848% |
| EC Healthcare | 737.83 Million HKD | 46.603% |
| Ming Fai International Holdings Limited | 211.83 Million HKD | -85.983% |
| Blue Moon Group Holdings Limited | 656.37 Million HKD | 39.977% |
| SuperRobotics Holdings Limited | -7.39 Million HKD | 5424.72% |
| Takbo Group Holdings Limited | 25.8 Million HKD | -1426.802% |
| Hyfusin Group Holdings Limited | 154.18 Million HKD | -155.518% |